Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

USP <797> Sterile Compounding and Aseptic Processing Training Program and USP <800> Training for Proper Handling of Hazardous Drugs


Date: May 15, 2018 08:00 AM - May 17, 2018 05:00 AM

Registration closes on May 12, 2018 11:55 PM

Target Audience(s)

  • Pharmacists
  • Pharmacy Technicians

Accreditation(s)

Accreditation Council for Pharmacy Education
VCU School of Pharmacy Office of Continuing Education program is accredited by the Accreditation Council for Pharmacy Education, 20 North Clark Street, Suite 2500, Chicago, IL 60602-5109, TEL (312) 664-3575 , FAX (312) 664-4652, URL www.acpeaccredit.org.

 

 

Registration closes on May 12, 2018 at 11:55 PM

Registration Closed  

Objectives

  • Illustrate the chronological evolution of pharmacy compounding up to present day USP Chapters <797> & <800>
  • Compare the roles of USP and FDA with regard to standards and enforcement
  • Apply relevant regulatory guidelines associated with pharmacy sterile compounding
  • Illustrate the typical layout of a cleanroom including primary and secondary engineering controls
  • Discuss the role of the pharmacist and pharmacy technicians’ responsibilities pertaining to sterile compounding
  • Demonstrate cleaning and disinfection of pharmacy controlled environments
  • Demonstrate proper personnel hand hygiene, garbing, gloved fingertip sampling and media fill tests
  • Compile the similarities and differences between sterile preparations with the various risk levels
  • Discuss the importance of appropriate beyond use dating principles

Activity Number

0294-0000-18-001-L07-P
Date: 05/15/18
Time: 08:00 AM - 05:00 PM

Fee

$795.00

Location

SOP Smith Pharmacy Room 545
Registration Closed  

Registration Closed  

Objectives

  • Illustrate the chronological evolution of pharmacy compounding up to present day USP Chapters <797> & <800>
  • Compare the roles of USP and FDA with regard to standards and enforcement
  • Apply relevant regulatory guidelines associated with pharmacy sterile compounding
  • Illustrate the typical layout of a cleanroom including primary and secondary engineering controls
  • Discuss the role of the pharmacist and pharmacy technicians’ responsibilities pertaining to sterile compounding
  • Demonstrate cleaning and disinfection of pharmacy controlled environments
  • Demonstrate proper personnel hand hygiene, garbing, gloved fingertip sampling and media fill tests
  • Compile the similarities and differences between sterile preparations with the various risk levels
  • Discuss the importance of appropriate beyond use dating principles
  • Provide an overview of USP Chapter <800> for hazardous drug compounding
  • Classify hazardous drugs along with risk assessment and approaches for exposure control
  • Identify potential challenges with USP Chapter 800 facility design requirements - primary engineering controls and secondary engineering controls - and strategies to address them
  • Discuss regulatory implications and considerations for operating a 503A Traditional Compounding Pharmacy vs. a 503B Outsourcing Facility
  • Describe compounding pharmacy scenarios that demonstrate the steps needed to achieve regulatory compliance with current hazardous drug handling standards
  • Discuss personnel training and competency assessment, personal protective equipment, proper donning and doffing of PPE for compounding hazardous drugs
  • Discuss best practices for minimizing exposure to hazardous drugs-labeling, packaging, transport, dispensing, spill management, disposal, administering-to prevent occupational exposure to hazardous drugs
  • Describe proper procedures for deactivating, decontaminating, cleaning and disinfecting primary engineering controls and secondary engineering controls used for compounding hazardous drugs
Date: 05/15/18
Time: 08:00 AM - 05:00 PM

Fee

$1,150.00
Registration Closed  

Registration Closed  

Objectives

  • Illustrate the chronological evolution of pharmacy compounding up to present day USP Chapters <797> & <800>
  • Compare the roles of USP and FDA with regard to standards and enforcement
  • Apply relevant regulatory guidelines associated with pharmacy sterile compounding
  • Illustrate the typical layout of a cleanroom including primary and secondary engineering controls
  • Discuss the role of the pharmacist and pharmacy technicians’ responsibilities pertaining to sterile compounding
  • Demonstrate cleaning and disinfection of pharmacy controlled environments
  • Demonstrate proper personnel hand hygiene, garbing, gloved fingertip sampling and media fill tests
  • Compile the similarities and differences between sterile preparations with the various risk levels
  • Discuss the importance of appropriate beyond use dating principles

Activity Number

0294-0000-18-001-L07-T
Date: 05/15/18
Time: 08:00 AM - 05:00 PM

Fee

$795.00

Location

SOP Smith Pharmacy Room 545
Registration Closed  

Registration Closed  

Objectives

  • Illustrate the chronological evolution of pharmacy compounding up to present day USP Chapters <797> & <800>
  • Compare the roles of USP and FDA with regard to standards and enforcement
  • Apply relevant regulatory guidelines associated with pharmacy sterile compounding
  • Illustrate the typical layout of a cleanroom including primary and secondary engineering controls
  • Discuss the role of the pharmacist and pharmacy technicians’ responsibilities pertaining to sterile compounding
  • Demonstrate cleaning and disinfection of pharmacy controlled environments
  • Demonstrate proper personnel hand hygiene, garbing, gloved fingertip sampling and media fill tests
  • Compile the similarities and differences between sterile preparations with the various risk levels
  • Discuss the importance of appropriate beyond use dating principles
  • Provide an overview of USP Chapter <800> for hazardous drug compounding
  • Classify hazardous drugs along with risk assessment and approaches for exposure control
  • Identify potential challenges with USP Chapter 800 facility design requirements - primary engineering controls and secondary engineering controls - and strategies to address them
  • Discuss regulatory implications and considerations for operating a 503A Traditional Compounding Pharmacy vs. a 503B Outsourcing Facility
  • Describe compounding pharmacy scenarios that demonstrate the steps needed to achieve regulatory compliance with current hazardous drug handling standards
  • Discuss personnel training and competency assessment, personal protective equipment, proper donning and doffing of PPE for compounding hazardous drugs
  • Discuss best practices for minimizing exposure to hazardous drugs-labeling, packaging, transport, dispensing, spill management, disposal, administering-to prevent occupational exposure to hazardous drugs
  • Describe proper procedures for deactivating, decontaminating, cleaning and disinfecting primary engineering controls and secondary engineering controls used for compounding hazardous drugs
Date: 05/15/18
Time: 08:00 PM - 05:00 PM

Fee

$1,150.00

Location

SOP Smith Pharmacy Room 545
Registration Closed  

Registration closes on May 12, 2018 at 11:55 PM

Registration Closed  

Objectives

  • Provide an overview of USP Chapter <800> for hazardous drug compounding
  • Classify hazardous drugs along with risk assessment and approaches for exposure control
  • Identify potential challenges with USP Chapter 800 facility design requirements - primary engineering controls and secondary engineering controls - and strategies to address them
  • Discuss regulatory implications and considerations for operating a 503A Traditional Compounding Pharmacy vs. a 503B Outsourcing Facility
  • Describe compounding pharmacy scenarios that demonstrate the steps needed to achieve regulatory compliance with current hazardous drug handling standards
  • Discuss personnel training and competency assessment, personal protective equipment, proper donning and doffing of PPE for compounding hazardous drugs
  • Discuss best practices for minimizing exposure to hazardous drugs-labeling, packaging, transport, dispensing, spill management, disposal, administering-to prevent occupational exposure to hazardous drugs
  • Describe proper procedures for deactivating, decontaminating, cleaning and disinfecting primary engineering controls and secondary engineering controls used for compounding hazardous drugs

Activity Number

0294-0000-18-002-L04-P
Date: 05/17/18
Time: 08:00 AM - 05:00 PM

Fee

$450.00

Location

SOP Smith Pharmacy Room 545
Registration Closed  

Registration Closed  

Objectives

  • Provide an overview of USP Chapter <800> for hazardous drug compounding
  • Classify hazardous drugs along with risk assessment and approaches for exposure control
  • Identify potential challenges with USP Chapter 800 facility design requirements - primary engineering controls and secondary engineering controls - and strategies to address them
  • Discuss regulatory implications and considerations for operating a 503A Traditional Compounding Pharmacy vs. a 503B Outsourcing Facility
  • Describe compounding pharmacy scenarios that demonstrate the steps needed to achieve regulatory compliance with current hazardous drug handling standards
  • Discuss personnel training and competency assessment, personal protective equipment, proper donning and doffing of PPE for compounding hazardous drugs
  • Discuss best practices for minimizing exposure to hazardous drugs-labeling, packaging, transport, dispensing, spill management, disposal, administering-to prevent occupational exposure to hazardous drugs
  • Describe proper procedures for deactivating, decontaminating, cleaning and disinfecting primary engineering controls and secondary engineering controls used for compounding hazardous drugs

Activity Number

0294-0000-18-002-L04-T
Date: 05/17/18
Time: 08:00 PM - 05:00 PM

Fee

$450.00

Location

SOP Smith Pharmacy Room 545
Registration Closed